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Lee).Sestrin 2 (SESN2) is a stress-inducible protein required for maintaining redox homeostasis. How-
ever, its mode of action remains to be clariﬁed. In this study, we found that SESN2 is induced in
human glioblastoma U87 cells following ionizing radiation (IR). SESN2 silencing not only results
in increased oxidative stress but also sensitizes U87 cells to IR. Intriguingly, we found SESN2 silenc-
ing signiﬁcantly increases the expression of platelet-derived growth factor receptor b (PDGFRb).
Using a double knockdown technique, we showed that inhibition of PDGFRb accumulation in
SESN2-silencing cells protects the cells from the deleterious effects induced by SESN2 silencing.
Taken together, we revealed that PDGFRb accumulation is associated with increased oxidative stress
and cellular damage in SESN2 silenced human glioblastoma U87 cells.
Crown Copyright  2011 Published by Elsevier B.V. on behalf of Federation of European Biochemical
society. All rights reserved.1. Introduction
Sestrin 2 (SESN2), originally identiﬁed as one of the hypoxia-
inducible genes in human glioblastoma cells (also known as
hypoxia-induced gene 95 or Hi95), is a member of the sestrin
family of proteins comprised of SESN1–SESN3 [1]. Based on
sequence homology to alkyl hydroperoxide reductase subunit D,
SESN2 was reported to be a disulﬁde reductase of peroxiredoxin
(Prx) [2], which may control the level of reactive oxygen species
(ROS) and prevent cells from severe ROS damage [3–5]. However,
SESN2 mediated reduction of overoxidized Prx remains controver-
sial because several reports have shown that sulﬁredoxin, rather
than SESN2, is responsible for reverting the peroxidase activity of
Prx in vitro and in vivo [6–9]. Nevertheless, ectopic expression of
SESN2 signiﬁcantly reduces ROS levels and increases cell viability,
whereas suppression of SESN2 increases intracellular ROS andd by Elsevier B.V. on behalf of Fede
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factor receptor b; Prx, perox-
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J. Lee), +886 2 27829142 (T.C.
tcl@ibms.sinica.edu.tw (T.-C.reduces cell viability following H2O2 exposure [2]. The expression
level of SENS2 is therefore considered critical for regulating the re-
dox homeostasis.
Both SESN1 and SESN2 contain PA26 domains belonging to the
DNA damage-inducible gene family [10]. These proteins are in-
volved in p53-mediated responses to a variety of stresses [11]. A
recent report demonstrated that ectopic expression of SESN1 and
SENS2 inhibited mTOR signaling and cell growth [12]. However,
deﬁciency of SESN2 in other cell lines resulted in evidently growth
inhibition instead of growth stimulation [2]. These studies indicate
that in responding to various stresses, the role of SESN2 is complex
and a detailed investigation is necessary.
In our study, we found that ionizing radiation (IR) signiﬁcantly
enhanced the expression of SESN2 in a human glioblastoma multi-
form cell line (U87), which is the most malignant brain tumor cell
line exhibiting drug resistance. To further explore the biological
roles of SESN2 in U87 cells, we used small interfering RNA (siRNA)
to silence SESN2 expression. We demonstrated that SESN2 silenc-
ing resulted in platelet-derived growth factor receptor b (PDGFRb)
accumulation. Double knockdown of SESN2 and PDGFRb prevented
the cells from an increase of ROS and growth inhibition observed
following SESN2 knockdown alone, indicating PDGFRb may serve
as a mediator for SESN2 to mediate oxidative stress and growth
inhibition.ration of European Biochemical society. All rights reserved.
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2.1. Cell culture and chemicals
Human glioblastoma multiform U87 cells (originally obtained
from Dr. John Y.H. Chan of the Chinese University of Hong Kong)
were cultured in MEM medium supplemented with 10% heat-
inactivated fetal bovine serum (FBS), 1 mM sodium pyruvate,
100 U/ml of penicillin and 100 lg/ml of streptomycin sulfate.
Irradiation was performed using an X-ray generator (Torrex
150D). Fetal bovine serum, sodium pyruvate, L-glutamine, mini-
mum essential medium, streptomycin, and trypsin were purchased
from Gibco BRL; hydroethidine (HE) was from Molecular Probes;
PDGF-BB and EGF were from Genetex; reverse transcriptase was
from Invitrogen; the protease inhibitor cocktail was purchased
from Roche; and X-Gal was from Bioman. All other chemicals were
obtained from Sigma.
2.2. siRNA targeting of genes
The siRNA sequence targeting SESN2 was 50-GACCAUGGCU
ACUCGCUGAdTdT-30 and that targeting PDGFRb was 50-GCCGU-
CAAGAUGCUUAAAU dTdTdTdT-30, according to Budanov et al. [2]
and Li et al. [13], respectively. Cells were transfected with annealed
oligonucleotides using Lipofectamine 2000 reagent (Invitrogen)
according to the manufacturer’s instructions and then incubated
in fresh medium for 48 h prior to further analysis. As a control, a
random sequence of annealed oligonucleotides (50-CGUACGCG-
GAAUACUUCGA dTdT-30) was transfected into U87 cells, and the
cells were designated as siC.
2.3. Immunoblot analysis
Cells were lysed in RIPA buffer (20 mM HEPES, pH 7.4, 150 mM
NaCl, 1% Triton X-100, 1 mM EGTA, 1 mM EDTA, 0.5% sodium
deoxycholate, 1 mM Na3VO4, 1 mM PMSF and complete protease
inhibitor cocktail) for 30 min on ice and centrifuged at 13 000g
for 15 min at 4 C. An aliquot of the lysate supernatant was mixed
with loading buffer, heated, subjected to SDS–PAGE analysis and
speciﬁc proteins were visualized by immunoblotting as described
[14]. The antibody against SESN2 was purchased from Abnova;
anti-PDGFRb was purchased from Calbiochem; anti-epidermal
growth factor receptor (EGFR) was from Cell Signaling; anti-lamin
A/C, anti-ubiquitin were from Santa Cruz Biotechnology; anti-beta-
actin, anti-alpha-tubulin were from Abcam; and anti-EEA1 was
from BD Transduction Laboratory.
2.4. Analysis of senescence
For detection of senescence, cells on plates were washed with
phosphate-buffered saline (PBS), ﬁxed with 2% formaldehyde/
0.2% glutaraldehyde, and incubated with fresh senescence-associ-
ated b-Gal (SA-b-Gal) staining solution as described [15] at 37 C
for 24 h. Cell nuclei were visualized by counterstaining with DAPI
(50 ng/ml in PBS).
2.5. Analysis of autophagy
To examine autophagosome formation, siC and siSESN2 cells
were transfected with GFP-LC3 expression vector (a gift from
Dr. Y.L. Lin, IBMS, Academia Sinica, Taiwan) or control GFP vector
using Fugene 6 according to the manufacturer’s instructions and
incubated for 48 h. The percentage of autophagic cells was deﬁned
as the number of GFP-LC3-dotted cells versus that of GFP-LC3-
ﬂuorescent cells [16].2.6. Measurement of intracellular ROS
At the end of treatment, cells were washed several times with
PBS and then incubated with 20 lM HE at 37 C for 15 min. HE is
oxidized by superoxides to yield ﬂuorescent ethidium, resulting
in red ﬂuorescence. After HE treatment, the cells were washed with
PBS and analyzed by ﬂow cytometry (FACSCalibur; Becton Dickin-
son, San Jose, CA, USA).
2.7. Subcellular fractionation
As described previously [17], cells were lysed in RIPA buffer and
the nuclear, heavy membrane, and light membrane fractions were
obtained as pellets following successive lysate centrifugations at
1000, 10 000 and 100 000g, respectively. The ﬁnal clear superna-
tant was the cytoplasmic fraction. An aliquot of each fraction was
subjected to SDS–PAGE and immunoblot analysis as described
above.
2.8. Immunohistochemical staining and confocal analysis
Cells seeded onto glass coverslips were ﬁxed in 3.7% formalde-
hyde followed by 70% cold ethanol. The coverslips were then incu-
bated with primary antibody against PDGFRb for 1 h at 37 C and
then with Alexa Fluor 488-conjugated anti-mouse IgG for 1 h at
37 C. Confocal images were acquired using a LSM510 META
microscope (Carl Ziess MicroImaging).
2.9. Reverse transcription (RT)-PCR
Total RNA was isolated and subjected to RT-PCR analysis. For
PCR reactions, 40 ng cDNA was used as template. The PCR primers
speciﬁc for the following genes were designed using LightCycler
Probe Design Software (Roche): PDGFRb forward primer 50-GCCCT-
GAGAGATCTGTGGTT-30 and reverse primer 50-TGTCCAGAGCCTG-
GAACTGT-30; SESN2 forward primer 50-AAGACCCTACTTTCGGA-30
and reverse primer 50-CTGCCTGGAACTTCTCAT-30; beta-2 micro-
globulin forward primer 50-CGCTACTCTCTCTTTCTGG-30 and
reverse primer 50-ACTTCAATGTCGGATGG-30. Beta-2 microglobulin
transcripts were used as the internal control.
2.10. Immunoprecipitation
Two milligrams total protein from siC or siSESN2 cell lysates
was incubated with anti-PDGFRb or anti-mouse IgG (negative
control) overnight at 4 C. Antigen–antibody complexes were
precipitated using protein A agarose beads for 1 h at 4 C. Immuno-
precipitated proteins were washed ﬁve times with PBST (0.1%
Tween-20) and subjected to immunoblotting.
2.11. Statistical analysis
All values are expressed as the mean ± standard deviation (S.D.).
The Student’s t-test for unpaired results was used to evaluate dif-
ferences between two groups. Differences were considered signif-
icant for ⁄P < 0.05 or ⁄⁄P < 0.01.
3. Results
3.1. SESN2 silencing sensitizes glioblastoma U87 cells to IR
Our preliminary study showed that SESN2 was induced by IR in
human glioblastoma U87 cells as selected frommicroarray analysis
(data not shown). To explore the role of SESN2, we knocked down
SESN2 expression by transfecting U87 cells with the SESN2 siRNA
Fig. 1. Increased susceptibility to radiation in U87 cells after SESN2 silencing. (A) U87 cells were transfected without or with control (siC) or SESN2 (siSESN2) siRNA and
incubated for 48 h (designated as day 0). Untransfected, siC, and siSESN2 cells were then irradiated (10 Gy) and incubated at 37 C for 24 h. SESN2 expression was examined
by immunoblotting with antibodies against SENS2 and actin (loading control). (B) siC and siSESN2 cells were irradiated with X-ray at 3 Gy and then incubated for 48 h (NT, no
treatment). Percent cell survival was then assessed by trypan blue staining. ⁄⁄P < 0.01, compared to siC cells. (C) siC or siSESN2 cells were exposed to 3 Gy irradiation and
incubated for 24 h. Superoxide anion levels were determined by ﬂow cytometry following HE staining. (D) After 3 Gy irradiation, siC and siSESN2 cells were incubated for
another 3 days and subjected to X-gal staining. Top, images of X-gal-positive cells; bottom, the percentage of X-gal-positive cells. (E) siC and siSESN2 cells were treated with
or without 3 Gy irradiation and incubated for 1 day. After incubation, siC and siSESN2 cells were transfected with a plasmid expressing GFP-LC3. After 2 days incubation, the
expression of dotted GFP-LC3 was examined under a ﬂuorescence microscope. NT, No treatment; IR, irradiated with X-ray; ⁄⁄P < 0.01, compared to siC cells.
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ted cells, SESN2 expression was substantially suppressed siSESN2
U87 cells with or without irradiation (Fig. 1A). The cellular suscep-
tibility to IR was greatly increased in siSESN2 cells as compared to
siC cells, using the trypan blue staining assay (Fig. 1B). We also
demonstrated that SESN2 silencing resulted in increased ROS
(Fig. 1C), senescence (Fig. 1D) and autophagy (Fig. 1E) in U87 cells
as compared to the vector transfected controls (siC cells) with or
without IR exposure. Increased autophagy was also observed by
acridine orange staining and transmission electron microscopy
analysis (data not shown). By aid of annexin V-based apoptosis
assay, a slight increase of apoptosis was observed in IR irradiated
siC and siSESN2. These results indicate that SESN2 silencing
increases ROS as well as senescence and autophagy, but also sensi-
tizes U87 cells to IR.
3.2. SESN2 silencing increases PDGFRb expression
While SESN2 was shown to involve in the regulation of cell
proliferation [2], we also observed SESN2 silencing decreased
the proliferation rate of U87 cells (Fig. 2A). Although ROS could
directly cause damage of intracellular macromolecules, ROS were
also involved in signaling pathways that control growth factor-stimulated proliferation [18]. We examined whether SENS2
silencing could modulate the proliferating effects of platelet-de-
rived growth factor subunit B (PDGF-BB) or epidermal growth fac-
tor (EGF) on U87 cells. As shown in Fig. 2B, exogenous EGF could
stimulate the growth of both siSESN2 and siC U87 cells, whereas
PDGF-BB only recovered the growth of siC cells but not that of
siSESN2 cells. We further examined protein levels of PDGFRb in
siSESN2 cells at different time intervals after transfection of siR-
NA. Interestingly, PDGFRb expression was signiﬁcantly increased
at day 0 (i.e., 48 h after transfection of control siRNA or SESN2
siRNA) and kept at high levels for at least 4 days in siSESN2 cells
(Fig. 2C). EGFR expression remained at the same levels with or
without SESN2 silencing (Fig. 2C). The localization of increased
PDGFRb in siSESN2 cells was biochemically revealed by cellular
fractionation analysis. As shown in Fig. 2D, PDGFRb was mainly
localized in heavy membrane fraction (HM) in siC cells, while
PDGFRb in siSESN2 cells was increased not only in heavy mem-
brane (HM) but also in light membrane (LM) and nuclear (N) frac-
tions. Confocal microscope analysis also conﬁrmed the wide
distribution of PDGFRb in the cytoplasm and nuclei of siSESN2
cells (Fig. 2E). These results suggested that the levels and location
of PDGFRb protein was dysregulated following SESN2 gene
silencing.
Fig. 2. Increased expression of PDGFRb in siSESN2 cells. (A) Cell density in siC or siSESN2 cells was examined by trypan blue staining on days 2, 3, and 4. ⁄⁄P < 0.01, compared
to siC cells. (B) siC and siSESN2 cells were incubated in serum-free media for 24 h and then treated with 100 ng/ml of platelet-derived growth factor subunit B (PDGF-BB) or
epidermal growth factor (EGF) for 48 h. Cell number was then determined by trypan blue staining. ⁄⁄P < 0.01, compared to no treatment control (NT). (C) PDGFRb, EGFR, and
SESN2 expression in siC and siSESN2 cells was examined by immunoblotting at days 0, 2, and 4 after siRNA transfection using antibodies against the proteins indicated at
right. (D) siC or siSESN2 cells were fractionated into cytosol (C), nucleus (N), heavy membrane (HM), and light membrane (LM) fractions. PDGFRb, EGFR and SESN2 levels in
each fraction were assessed by immunoblotting using antibodies against the proteins indicated at right. EEA1 and lamin A/C were served as markers for HM and N,
respectively. (E) PDGFRb localization in siC and siSESN2 cells was analyzed by immunohistochemical staining (green) and examined under a confocal microscopy. Cells were
counterstained with DAPI (blue).
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To understand how PDGFRb was increased in siSESN2 cells, we
ﬁrst compared the levels PDGFRb transcript in siC and siSESN2
cells by RT-PCR technique. As shown in Fig. 3A, SESN2 silencing
did not change the transcription of PDGFRb (Fig. 3A). Because we
did not observe any increase of PDGFRb translation in siSESN2 cells
following 35S-amino acid labeling (data not shown), we treated
U87 cells with cycloheximide to chase the degradation rate of
PDGFRb in siC and siSESN2 cells. Apparently, the degradation of
PDGFRb in siSESN2 cells was slower in siSESN2 cells than in siC
cells (Fig. 3B). From the quantiﬁcation data shown in Fig. 3C, the
half-life of PDGFRb was extended from 6 h in siC cells to 16.8 h
in siSESN2 cells. We further detected the levels of ubiquitinyl con-
jugation onto PDGFRb using the immunoprecipitation/immunoblot
techniques. In consistent with previous ﬁndings, there was a 3.9-
fold of PDGFRb precipitated from siSESN2 cells as compared from
siC cells (Fig. 3D). However, the ubiquitinyl-conjugated PDGFRb
in siSESN2 cells was 0.8-fold to that in siC cells, indicating that
the ubiquitination of PDGFRb in SESN2-silencing cells was less efﬁ-
cient than in siC cells. These results suggested that SESN2 silencing
resulted in accumulated PDGFRb proteins via blockage of the pro-
tein ubiquitination and degradation.3.4. PDGFRb accumulation is involved in SESN2 silencing induced ROS
and cell damage
The ﬁndings about the accumulation of PDGFRb in siSESN2 cells
prompted us to investigate whether SESN2 silencing induced oxi-
dative damage and growth inhibition was triggered by PDGFRb
accumulation or not. As revealed in Fig. 4A, concomitant transfec-
tion of SESN2 and PDGFRb siRNAs successfully silenced both SESN2
and PDGFRb (siSESN2/P cells). Knockdown of SESN2 alone gener-
ated higher level of superoxide anions (Fig. 4B), whereas double
knockdown of SESN2 and PDGFRb decreased oxidative damage in-
duced by SESN2 silencing. Moreover, SESN2 silencing-triggered
autophagy was also reduced in the absence of PDGFRb (Fig. 4C).
As to cell proliferation, the growth inhibitory effect in siSESN2 cells
was partially relieved after double silencing of SESN2 and PDGFRb
(Fig. 4D). These data reveal that PDGFRb accumulation plays a cru-
cial role on the SESN2 silencing induced ROS and deleterious cell
damage.
4. Discussion
Our results indicate that SESN2 silencing impairs the degrada-
tion of PDGFRb and consequently elevates ROS levels and increases
Fig. 3. PDGFRb degradation is attenuated in siSESN2 cells. (A) PDGFRb mRNA levels in siC and siSESN2 cells were examined by RT-PCR at 0, 1, and 5 days after siRNA
transfection. SESN2 and beta-2 microglobulin (B2M) mRNA levels were analyzed as controls. (B) siC and siSESN2 cells were treated with 10 lg/ml of cycloheximide (CHX) for
the indicated times and then subjected to immunoblotting with antibodies against the proteins indicated at right. (C) Half-life of PDGFRb protein in siC and siSESN2 cells. As
described in (B), protein levels of PDGFRb in siC and siSESN2 cells treated with cycloheximide for 0–48 h were accessed by immunoblots and quantiﬁed by a densitometer.
⁄⁄P < 0.01, compared to siC cells. (D) Ubiquitination of PDGFRb in siC and siSESN2 cells was examined by immunoprecipitation (IP) with an antibody against PDGFRb.
Immunoprecipitated proteins were then subjected to immunoblotting with antibodies against the proteins indicated at right. PDGFRb and ubiquitinated PDGFRb (Ubi-
PDGFRb) levels relative to tubulin were quantiﬁed by densitometry, and values are indicated below the immunoblots.
Fig. 4. Double knockdown of SESN2 and PDGFRb alleviates SESN2 silencing-mediated cellular injury. (A) U87 cells were transfected with control, SESN2, PDGFRb, or SESN2
and PDGFRb (siSESN2/P) siRNAs and subjected to immunoblotting with the antibodies indicated at right. (B) The ROS levels in siC, siSESN2, siPDGFRb, and siSESN2/P cells
were determined by staining with HE at day 3 (⁄⁄P < 0.01). (C) As described in Fig. 1E, the percentage of GFP-LC3 dotted cells was determined in siC, siSESN2, siPDGFRb, and
siSESN2/P cells. (D) Cell density in siC, siSESN2, siPDGFRb, and siSESN2/P cells was examined by trypan blue staining on days 3 (⁄P < 0.05).
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fenses against ROS remains to be obscure. Intriguingly, we found
that PDGFRb was abnormally accumulated after SESN2 silencing.
Our double knockdown experiments obviously support that SESN2
silencing induces PDGFRb accumulation which plays certain roles
to interfere with ROS balance, resulting in increased oxidative
damage and cell growth inhibition.How PDGFRb accumulation associates with ROS generation is
not clear currently. Usually, ROS are originated from several
sources such as leakage from electron transport chain in mitochon-
drion, production by NADPH oxidase in plasma membrane and
endosome, lipofuscin in lysosome [19,20]. PDGFRb was shown to
enhance NADPH oxidase activity with ROS production via Rac-1
activation [21]. After ligand stimulation, we observed a higher level
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mainly accumulated in light membrane fractions and nuclei in siS-
ESN2 cells, we may infer that accumulated PDGFRb in siSESN2 may
generate higher ROS via NADPH oxidase and facilitate the forma-
tion of autophagic vesicles. However, further investigation is
required.
Our present results showed that PDGFRb accumulation is likely
due to slow degradation. Upon ligand binding, PDGF receptor
forms dimerization and autophosphorylation and internalized
PDGF receptor can recycle back to cell membrane or be sorted to
degradation pathway [22]. Meanwhile, PDGF also triggers ubiqui-
tin-dependent degradation of its receptor via both proteasomes
and lysosomes by Cbl [23,24]. From immunoprecipitation analysis,
we observed lower level of ubiquitination on PDGFRb after SESN2
silencing (Fig. 3D), implying the sorting signal on PDGFRb was dis-
turbed following SESN2 knockdown.
Our ﬁndings showed that SESN2 silencing enhanced cell death
in glioblastoma U87 cells following IR exposure. Because knock-
down of SESN2 combining ROS-generating agents enhances drug
cytotoxicity through induction of senescence and autophagy, drug
targeting of SESN2 may provide a clue for further development of a
redox-based therapy to overcome the challenge of resistance of
malignant cancer cells to current therapies.
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